1. Immunology/Inflammation NF-κB Metabolic Enzyme/Protease
  2. Reactive Oxygen Species (ROS)
  3. Procyanidin B2

プロシアニジン B2  (Synonyms: Procyanidin B2; Proanthocyanidin B2)

製品番号: HY-N0796 純度: 99.89%
COA 取扱説明書 Technical Support

Procyanidin B2 is a natural flavonoid, with anti-cancer, antioxidant activities.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号 : 29106-49-8

容量 価格(税別) 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 140 在庫あり
Solution
10 mM * 1 mL in DMSO USD 140 在庫あり
Solid
1 mg $55 在庫あり
5 mg $110 在庫あり
10 mg $195 在庫あり
25 mg $450 在庫あり
50 mg $675 在庫あり
100 mg $980 在庫あり
200 mg   お問い合わせ  
500 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 17 publication(s) in Google Scholar

Other Forms of Procyanidin B2:

Top Publications Citing Use of Products

    Procyanidin B2 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2022 Jul 11;13(7):594.  [Abstract]

    The indicated dosages of PCB2 (Procyanidin B2) were injected intraperitoneally for three consecutive days before the operation. Representative images of the H&E-stained lung tissue.

    Procyanidin B2 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2022 Jul 11;13(7):594.  [Abstract]

    A549 cells were treated with 20 μM PCB2 (Procyanidin B2) for 24 hours, followed by 6 hours of hypoxia and then 2 hours of reoxygenation to establish a hypoxia/reoxygenation injury model. A representative FACS scatter plot of Annexin V and propidium iodide dual labeling is shown.

    Procyanidin B2 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2022 Jul 11;13(7):594.  [Abstract]

    A549 cells were treated with 20 μM PCB2 (Procyanidin B2) for 24 hours, followed by 6 hours of hypoxia and then 2 hours of reoxygenation to establish a hypoxia/reoxygenation injury model. The expression of Bcl-2 protein in lung tissue was investigated.

    Procyanidin B2 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2022 Jul 11;13(7):594.  [Abstract]

    C57BL/6 mice were intraperitoneally injected with 30 mg/kg PCB2 (Procyanidin B2) for three consecutive days. SIRT3 immunohistochemical staining was performed.

    Procyanidin B2 purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2022 Jul 11;13(7):594.  [Abstract]

    I/R mice were subjected to 1 hour of ischemia and 2 hours of reperfusion to induce lung I/R injury. Control mice underwent sham surgery. Preoperative intraperitoneal injections of PCB2 (Procyanidin B2: 30 mg/kg) were administered for three consecutive days prior to surgery. Representative images of A549 cells stained with TUNEL; cell nuclei were stained with DAPI.
    • 生物活性

    • プロトコル

    • 純度とドキュメンテーション

    • 参考文献

    • カスタマーレビュー

    製品説明

    Procyanidin B2 is a natural flavonoid, with anti-cancer, antioxidant activities.

    Cellular Effect
    Cell Line Type Value Description References
    A549 ED50
    > 10 μg/mL
    Compound: 48
    Cytotoxicity against human A549 cells by tetrazolium salt-based colorimetric assay
    Cytotoxicity against human A549 cells by tetrazolium salt-based colorimetric assay
    [PMID: 1431932]
    HCT-8 ED50
    > 10 μg/mL
    Compound: 48
    Cytotoxicity against human HCT8 cells by tetrazolium salt-based colorimetric assay
    Cytotoxicity against human HCT8 cells by tetrazolium salt-based colorimetric assay
    [PMID: 1431932]
    HUVEC IC50
    3.8 μM
    Compound: 44
    Inhibition of NADPH oxidase in Homo sapiens (human) HUVEC cells
    Inhibition of NADPH oxidase in Homo sapiens (human) HUVEC cells
    10.1007/s00044-012-0353-y
    KB ED50
    > 10 μg/mL
    Compound: 48
    Cytotoxicity against human KB cells by tetrazolium salt-based colorimetric assay
    Cytotoxicity against human KB cells by tetrazolium salt-based colorimetric assay
    [PMID: 1431932]
    MT4 CC50
    135.1 μg/mL
    Compound: 2, procyanidin B2
    Cytotoxicity against human MT4 cells by MTT assay
    Cytotoxicity against human MT4 cells by MTT assay
    [PMID: 10425115]
    MT4 IC50
    17.2 μg/mL
    Compound: 2, procyanidin B2
    Antiviral activity against HIV infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
    Antiviral activity against HIV infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect by MTT assay
    [PMID: 10425115]
    TE-671 ED50
    > 10 μg/mL
    Compound: 48
    Cytotoxicity against human TE671 cells by tetrazolium salt-based colorimetric assay
    Cytotoxicity against human TE671 cells by tetrazolium salt-based colorimetric assay
    [PMID: 1431932]
    体外実験

    Procyanidin B2 shows antiproliferative activity to MCF-7 cells, with an IC50 of 19.21 μM. However, Procyanidin B2 exhibits no effect on DNA-ladder formation[1]. Procyanidin B2 (0.1, 1, 2 μM) inhibits the activation of pyrin domain containing 3 (NLRP3) inflammasome in human umbilical vein ECs (HUVECs), and the inhibition is via suppression of AP-1 activity, and such effect can be abolished by overexpression of c-Jun. Procyanidin B2 (2 μM for 12 h) also reduces ROS in HUVECs[2].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    体内実験

    Procyanidin B2 (40, 20, and 10 mg/kg, p.o.) protects against cerebral ischemia-induced infarct volume and brain edema in rats. Procyanidin B2 (40 mg/kg, p.o) also improves functional outcomes, regulates blood-brain barrier (BBB) permeability after cerebral ischemia. Moreover, Procyanidin B2 attenuates cerebral ischemia-induced tight junction degradation, mitochondrial depolarization and intracellular oxidative stress. Procyanidin B2 (40 mg/kg, p.o) increases Nrf2 activation and HO-1, GSTα, and NQO1 protein expression in normal brains in vivo[3].

    MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

    臨床実験
    分子量

    578.52

    分子式

    C30H26O12

    CAS 番号
    Appearance

    Solid

    Color

    Light yellow to light brown

    SMILES

    O[C@H]1[C@@H](C2=CC=C(O)C(O)=C2)OC3=CC(O)=CC(O)=C3[C@@H]1C4=C5C(C[C@@H](O)[C@@H](C6=CC=C(O)C(O)=C6)O5)=C(O)C=C4O

    Structure Classification
    Initial Source
    輸送条件

    Room temperature in continental US; may vary elsewhere.

    保管条件
    Powder -20°C 3 years
      4°C 2 years
    In solvent -80°C 6 months
      -20°C 1 month
    溶剤 & 溶解度
    体外: 

    H2O : 66.67 mg/mL (115.24 mM; Need ultrasonic)

    DMSO : ≥ 50 mg/mL (86.43 mM; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 1.7285 mL 8.6427 mL 17.2855 mL
    5 mM 0.3457 mL 1.7285 mL 3.4571 mL
    10 mM 0.1729 mL 0.8643 mL 1.7285 mL
    View the Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • Molarity Calculator

    • Dilution Calculator

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass
    =
    Concentration
    ×
    Volume
    ×
    Molecular Weight *

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始)

    C1

    ×
    体積 (開始)

    V1

    =
    濃度 (終了)

    C2

    ×
    体積 (終了)

    V2

    体内:

    Select the appropriate dissolution method based on your experimental animal and administration route.

    For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
    To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

      Solubility: ≥ 2.5 mg/mL (4.32 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

      Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
    • Protocol 2

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

      Solubility: ≥ 2.5 mg/mL (4.32 mM); Clear solution

      This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

      Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

      Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.

    For the following dissolution methods, please prepare the working solution directly. It is recommended to prepare fresh solutions and use them promptly within a short period of time.
    The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

    • Protocol 1

      Add each solvent one by one:  PBS

      Solubility: 50 mg/mL (86.43 mM); Clear solution; Need ultrasonic

    In Vivo Dissolution Calculator
    Please enter the basic information of animal experiments:

    Dosage

    mg/kg

    Animal weight
    (per animal)

    g

    Dosing volume
    (per animal)

    μL

    Number of animals

    Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
    Calculation results:
    Working solution concentration: mg/mL
    This product has good water solubility, please refer to the measured solubility data in water/PBS/Saline for details.
    The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only.If necessary, please contact MedChemExpress (MCE).
    純度とドキュメンテーション

    純度: 99.89%

    参考文献
    細胞実験
    [1]

    MCF-7 cells are grown in 5 mL of RPMI 1640 medium supplemented with 20% fetal bovine serum, penicillin (100 U/mL) and streptomycin (100 μg/mL). Cells are maintained at 37°C in a humidified atmosphere of 5% CO2 in air and subcultured every 3 days. Exponentially growing cells are plated at a seeding density of 2×104 cells/mL, in 96-well plates or in dishes. After overnight incubation to allow for attachment, the cells are exposed for 24 or 48 h to various concentrations of Procyanidin B2 (0.5; 1.0; 5.0; 10.0; 25.0 and 50.0 μM) diluted in distilled water. Two millimolar cyclophosphamide (CP) is used as the positive control and solutions are sterilised by filtration[1].

    MedChemExpress (MCE) はこれらの方法の精度を確認していません。 こちらは参照専用です。

    動物実験
    [3]

    To observe the effect of Procyanidin B2 on infarct size or brain edema, 40 rats are randomLy separated into five groups, and each group is administered with vehicle (equivalent dose of 0.9% saline administered via gavage) or 40, 20, or 10 mg/kg of Procyanidin B2, respectively. To elucidate the effect of Procyanidin B2 on blood-brain barrier (BBB) permeability, the rats (n = 6 per group for Evans blue extravasation and n = 4 per group for IgG leakage) are randomLy separated into two groups: vehicle and Procyanidin B2 (40 mg/kg). Procyanidin B2 (40 mg/kg) is administered intragastrically once a day starting at 3 h after middle cerebral artery occlusion (MCAO). For other observations, including immunohistological staining and western blot analysis, rats are randomLy separated into three groups: sham-operated, vehicle, and Procyanidin B2 (n = 4 per group). Procyanidin B2 (40 mg/kg) is administered intragastrically once a day starting at 3 h after MCAO. To elucidate the improvement in neurological function after ischemic stroke in rats, the rats (n = 8 per group) undergo neurobehavioral assays to evaluate the functional outcome after administration of Procyanidin B2 (40 mg/kg) once a day starting at 24 h after MCAO. The neurological deficits are assessed at 1, 3, 7, 11, and 14 days after MCAO[3].

    MedChemExpress (MCE) はこれらの方法の精度を確認していません。 こちらは参照専用です。

    参考文献

    Complete Stock Solution Preparation Table

    * Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
    Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

    Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
    DMSO / H2O 1 mM 1.7285 mL 8.6427 mL 17.2855 mL 43.2137 mL
    5 mM 0.3457 mL 1.7285 mL 3.4571 mL 8.6427 mL
    10 mM 0.1729 mL 0.8643 mL 1.7285 mL 4.3214 mL
    15 mM 0.1152 mL 0.5762 mL 1.1524 mL 2.8809 mL
    20 mM 0.0864 mL 0.4321 mL 0.8643 mL 2.1607 mL
    25 mM 0.0691 mL 0.3457 mL 0.6914 mL 1.7285 mL
    30 mM 0.0576 mL 0.2881 mL 0.5762 mL 1.4405 mL
    40 mM 0.0432 mL 0.2161 mL 0.4321 mL 1.0803 mL
    50 mM 0.0346 mL 0.1729 mL 0.3457 mL 0.8643 mL
    60 mM 0.0288 mL 0.1440 mL 0.2881 mL 0.7202 mL
    80 mM 0.0216 mL 0.1080 mL 0.2161 mL 0.5402 mL
    H2O 100 mM 0.0173 mL 0.0864 mL 0.1729 mL 0.4321 mL

    * Note: If you choose water as the stock solution, please dilute it to the working solution, then filter and sterilize it with a 0.22 μm filter before use.

    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    質量   濃度   体積   分子量 *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    一般には略語で表示されます:C1V1 = C2V2

    濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
    × = ×
    C1   V1   C2   V2
    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    最近チェックした製品:

    オンラインお問い合わせ

    Your information is safe with us. * Required Fields.

    製品名

     

    カスタマ需要量 *

    お名前 *

     

    タイトル

    メールアドレス *

     

    電話番号 *

    デパートメント

     

    組纖名 *

    市区町村

    都道府県

    国或いは地域 *

         

    必ず会社名を記載ください。個人への返信は行いません。

    備考

    バルクお問い合わせ

    Inquiry Information

    製品名:
    Procyanidin B2
    製品番号:
    HY-N0796
    数量:
    MCE 日本正規代理店: